Skip to main content

Advertisement

Log in

Pyridine Derivative of Succinic Acid Hydroxylamide Enhances the Cytotoxic Effect of Cisplatin and Actinomycin D

  • BIOPHYSICS AND BIOCHEMISTRY
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

We studied the possibility of inhibition of histone deacetylases (HDAC) in the nuclear extract of HeLa cells by N1-hydroxy-N4-(pyridin-4-yl)succinamide (compound 1). Compound 1 inhibits HDAC and showed low toxicity for A-172, HepG2, HeLa, MCF-7, and Vero cells. HeLa cells were most sensitive to the compound. Increasing the interval between administration of compound 1 and the chemotherapeutic agent to 8 h led to an increase in the cytotoxic effect of cisplatin (actinomycin D) on HeLa cells. The combination of compound 1 with cisplatin (actinomycin D) reduced the cytotoxic effect of these drugs for non-tumor Vero cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Jin KL, Park JY, Noh EJ, Hoe KL, Lee JH, Kim JH, Nam JH. The effect of combined treatment with cisplatin and histone deacetylase inhibitors on HeLa cells. J. Gynecol. Oncol. 2010;21(4):262-268. https://doi.org/10.3802/jgo.2010.21.4.262

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Ramaiah MJ, Tangutur AD, Manyam RR. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy. Life Sci. 2021;277:119504. https://doi.org/10.1016/j.lfs.2021.119504

  3. Kulinchik TV. Cisplatin: discovery of antitumor activity. Med. Tekhnol. Otsenka Vybor. 2013;(1):87-90. Russian.

  4. Barabas K, Milner R, Lurie D, Adin C. Cisplatin: a review of toxicities and therapeutic applications. Vet. Comp. Oncol. 2008;6(1):1-18. https://doi.org/10.1111/j.1476-5829.2007.00142.x

    Article  CAS  PubMed  Google Scholar 

  5. Lamture G, Crooks PA, Borrelli MJ. Actinomycin-D and dimethylamino-parthenolide synergism in treating human pancreatic cancer cells. Drug Dev. Res. 2018;79(6):287-294. https://doi.org/10.1002/ddr.21441

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Hontecillas-Prieto L, Flores-Campos R, Silver A, de Álava E, Hajji N, García-Domínguez DJ. Synergistic enhancement of cancer therapy using HDAC inhibitors: opportunity for clinical trials. Front. Genet. 2020;11:578011. https://doi.org/10.3389/fgene.2020.578011

  7. Yu L, Liu F, Chen Y, You Q. Pharmacophore identification of hydroxamate HDAC 1 inhibitors. Chin. J. Chem. 2009;27(3):557-564. https://doi.org/10.1002/cjoc.200990091

    Article  CAS  Google Scholar 

  8. Tretyakov BA, Gadomskij SYa, Luzhkov VB, Terentev AA. Patent RU No. 2769320. Method for producing derivatives of N-hydroxybutanamide. Bull. No. 10. Published March 30, 2022.

  9. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl Acad. Sci. USA. 1989;86(7):2336-2340. https://doi.org/10.1073/pnas.86.7.2336

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Mosmann T. Rapid colorimetric assay for cellular growth and survivals: application to proliferation and cytotoxity assay. J. Immunol. Methods. 1983;65(1-2):55-63. https://doi.org/10.1016/0022-1759(83)90303-4

    Article  CAS  PubMed  Google Scholar 

  11. Tóth KF, Knoch TA, Wachsmuth M, Frank-Stöhr M, Stöhr M, Bacher CP, Müller G, Rippe K. Trichostatin A-induced histone acetylation causes decondensation of interphase chromatin. J. Cell Sci. 2004;117(Pt 18):4277-4287. https://doi.org/10.1242/jcs.01293

    Article  CAS  PubMed  Google Scholar 

  12. Martínez-Iglesias O, Ruiz-Llorente L, Sánchez-Martínez R, García L, Zambrano A, Aranda A. Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer. Clin. Transl. Oncol. 2008;10(7):395-398. https://doi.org/10.1007/s12094-008-0221-x

    Article  CAS  PubMed  Google Scholar 

  13. Reichling J, Schnitzler P, Suschke U, Saller R. Essential oils of aromatic plants with antibacterial, antifungal, antiviral, and cytotoxic properties — an overview. Forsch. Komplementmed. 2009;16(2):79-90. https://doi.org/10.1159/000207196

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. A. Tretyakov.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 175, No. 1, pp. 29-33, January, 2023

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tretyakov, B.A., Filatova, N.V., Mumyatova, V.A. et al. Pyridine Derivative of Succinic Acid Hydroxylamide Enhances the Cytotoxic Effect of Cisplatin and Actinomycin D. Bull Exp Biol Med 175, 23–26 (2023). https://doi.org/10.1007/s10517-023-05803-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-023-05803-4

Keywords

Navigation